Source: #GLP1 #MentalHealth #MetabolicHealth #Longevity #HealthLongevitySecrets Once someone loses the weight and wants to discontinue use, thats where a lot of the real questions begin
The longer treatment duration, 68 weeks versus 48 weeks in Phase 2, demonstrates that retatrutide continues to produce weight loss well beyond the initial year
Patients can expect to lose a significant percentage of their body weight when combined with lifestyle changes
On the analytics side, integrated platforms (like Paintor, CoverMyMeds, ClaritasRx) can correlate PBM metrics with prescribing behavior
That triple mechanism makes it the most powerful weight loss peptide in clinical development, with phase 2 trial participants losing up to 24.2% of their body weight at the highest dose
Elderly persons who find it more difficult to exercise due to a reduced metabolic rate may benefit from Retatrutide